Back to search

Article

Use of molnupiravir: a Danish nationwide drug utilization study

2023-02-27

Abstract excerpt

<h4>Purpose: </h4> To describe utilization patterns, characteristics of users and prescriber responsibility of the new oral antiviral medication, molnupiravir, indicated for mild-to-moderate COVID-19. <h4>Methods: </h4> Using nationwide registries, we identified all Danish adults who filled a prescription for molnupiravir from December 16 th , 2021, to August 31 st , 2022. We described weekly incidence rates an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4c47e26-de01-5296-b76e-31d010f07720
DOI
10.22541/au.167748286.69103593/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of molnupiravir: a Danish nationwide drug utilization studyDOI 10.22541/au.167748286.69103593/v1
Evaluating Nirmatrelvir-Ritonavir (Paxlovid®) in Outpatient COVID-19 Treatment: Safety, Tolerability, and Adherence Insights from Primary Healthcare ClinicsSemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large State-wide Health System During the Pandemic in 2020Semantic proximity
Self-reported pharmacogenetic medication use in the <i>Our Future Health</i> cohortSemantic proximity
Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir against mortality, hospitalization, and in-hospital outcomes among community-dwelling, ambulatory COVID-19 patients during the BA.2.2 wave in Hong Kong: an observational studySemantic proximity
Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity
Medication use patterns among older patients in temporary stays in DenmarkSemantic proximity
Evaluating Drug Interaction Risks: Nirmatrelvir &amp; Ritonavir Combination (PAXLOVID®) with Concomitant Medications in Real-World Clinical SettingsSemantic proximity
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.Semantic proximity
Prescription volume and costs of over-the-counter–like drugs in Japan by patient and healthcare facility characteristics: A nationwide descriptive studySemantic proximity
Metformin at the time of Covid-19 infection and risk of Long Covid: A Target Trial Emulation StudySemantic proximity
Select a neighboring publication to make it the new centre.